Found: 18
Select item for more details and to access through your institution.
Evidence that a STAT3 Mutation Causing Hyper IgE Syndrome Leads to Repression of Transcriptional Activity.
- Published in:
- Case Reports in Immunology, 2019, p. 1, doi. 10.1155/2019/1869524
- By:
- Publication type:
- Article
Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100324
- By:
- Publication type:
- Article
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2018, v. 14, p. N.PAG, doi. 10.1186/s13223-018-0253-x
- By:
- Publication type:
- Article
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 4, p. 1, doi. 10.26508/lsa.202302529
- By:
- Publication type:
- Article
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacks.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacks.
- Published in:
- Clinical Medicine, 2015, v. 15, n. 1, p. 101, doi. 10.7861/clinmedicine.15-1-101
- By:
- Publication type:
- Article
NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.706737
- By:
- Publication type:
- Article
Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?
- Published in:
- Frontiers in Immunology, 2021, p. N.PAG, doi. 10.3389/fimmu.2020.604512
- By:
- Publication type:
- Article
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 3, p. 500, doi. 10.1007/s10875-021-01181-6
- By:
- Publication type:
- Article
Successful Treatment of a Patient with Chronic Systemic Capillary Leak Syndrome, Neutropenia and Thymoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Quantification of human C1 esterase inhibitor protein using an automated turbidimetric immunoassay.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HAE international home therapy consensus document.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2010, v. 6, p. 1, doi. 10.1186/1710-1492-6-22
- By:
- Publication type:
- Article
Berotralstat for the prophylaxis of hereditary angioedema—Real‐world evidence data from the United Kingdom.
- Published in:
- Allergy, 2023, v. 78, n. 5, p. 1380, doi. 10.1111/all.15641
- By:
- Publication type:
- Article
Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1451813
- By:
- Publication type:
- Article
The Effects of Social Desirability on Students' Self-Reports in Two Social Contexts: Lectures vs. Lectures and Lab Classes.
- Published in:
- Information (2078-2489), 2022, v. 13, n. 10, p. 491, doi. 10.3390/info13100491
- By:
- Publication type:
- Article
A robust model for read count data in exome sequencing experiments and implications for copy number variant calling.
- Published in:
- Bioinformatics, 2012, v. 28, n. 21, p. 2747, doi. 10.1093/bioinformatics/bts526
- By:
- Publication type:
- Article
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 5, p. 763, doi. 10.1002/art.42772
- By:
- Publication type:
- Article